Software Treatment for Actively Reducing Severity of ADHD

NACompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DEVICE

AKL-T01

Videogame-like digital therapy

DEVICE

AKL-T09

Videogame-like digital therapy

Trial Locations (20)

21205

Kennedy Krieger Institute, Baltimore

27606

The Neuropsychiatric Clinic at Carolina Partners, Raleigh

27705

Duke Child and Family Study Center, Durham

32751

Florida Clinical Research Center, Maitland

34208

Meridien Research, Bradenton

36303

Harmonex Neuroscience Research, Dothan

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

60048

Capstone Clinical Research, Libertyville

63304

Midwest Research Group, Saint Charles

73103

IPS Research Company, Oklahoma City

75231

FutureSearch Trials, Dallas

77007

Bayou City Research, Ltd, Houston

85254

Melmed Center, Scottsdale

89128

Center for Psychiatry and Behavioral Medicine, Las Vegas

92660

Avida, Inc., Newport Beach

94143

University of California, San Francisco, San Francisco

95817

University of California Davis MIND Institute, Sacramento

98007

Northwest Clinical Research Center, Bellevue

98121

Seattle Children's, Seattle

02050

South Shore Psychiatric Services, Marshfield

All Listed Sponsors
lead

Akili Interactive Labs, Inc.

INDUSTRY

NCT02674633 - Software Treatment for Actively Reducing Severity of ADHD | Biotech Hunter | Biotech Hunter